Diag Capital Management’s Amgen AMGN Stock Holding History

Diag Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$3.92M	Buy	+20,110	New	+$3.92M	4.48%	8

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diag Capital Management's AMGN Position: Q4 2018 in Review

Diag Capital Management opened a new position in Amgen (AMGN) in Q4 2018: 20,110 shares worth $3.92M. The stake represents 4.48% of the portfolio and ranks #8 among its holdings.

1,892 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

Diag Capital Management held 20,110 shares of Amgen worth $3.92M as of Q4 2018.
Amgen was a new Diag Capital Management position in Q4 2018.
Amgen made up 4.48% of Diag Capital Management's portfolio in Q4 2018, its #8 holding.
1,892 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.